Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 26299 entries
Sorted by: Best Match Show Resources per page
The cryopreservation of liposomes. 1. A differential scanning calorimetry study of the thermal behavior of a liposome dispersion containing mannitol during freezing/thawing.

Pharmaceutical research

Talsma H, van Steenbergen MJ, Salemink PJ, Crommelin DJ.
PMID: 1924154
Pharm Res. 1991 Aug;8(8):1021-6. doi: 10.1023/a:1015857008057.

The thermal behavior of water in liposome dispersions and in liposome dispersions containing mannitol at subzero temperatures was investigated with differential scanning calorimetry (DSC). The cooling curves from 20 down to -60 degrees C for a liposome dispersion (bilayer...

Cite
Talsma H, van Steenbergen MJ, Salemink PJ, et al. The cryopreservation of liposomes. 1. A differential scanning calorimetry study of the thermal behavior of a liposome dispersion containing mannitol during freezing/thawing. Pharm Res. 1991;8(8):1021-6doi: 10.1023/a:1015857008057.
Talsma, H., van Steenbergen, M. J., Salemink, P. J., & Crommelin, D. J. (1991). The cryopreservation of liposomes. 1. A differential scanning calorimetry study of the thermal behavior of a liposome dispersion containing mannitol during freezing/thawing. Pharmaceutical research, 8(8), 1021-6. https://doi.org/10.1023/a:1015857008057
Talsma, H, et al. "The cryopreservation of liposomes. 1. A differential scanning calorimetry study of the thermal behavior of a liposome dispersion containing mannitol during freezing/thawing." Pharmaceutical research vol. 8,8 (1991): 1021-6. doi: https://doi.org/10.1023/a:1015857008057
Talsma H, van Steenbergen MJ, Salemink PJ, Crommelin DJ. The cryopreservation of liposomes. 1. A differential scanning calorimetry study of the thermal behavior of a liposome dispersion containing mannitol during freezing/thawing. Pharm Res. 1991 Aug;8(8):1021-6. doi: 10.1023/a:1015857008057. PMID: 1924154.
Copy Download .nbib Format: NLM
A study of the stability of W/O/W multiple emulsions.

Journal of microencapsulation

Yan N, Zhang M, Ni P.
PMID: 1593397
J Microencapsul. 1992 Apr-Jun;9(2):143-51.

The stability of W/O/W emulsions has been studied in batch agitators. The surfactants suitable for W/O/W emulsions were screened and the factors affecting the emulsion stability were also studied. Results showed that polyamine E644 was an excellent emulsifier for...

Cite
Yan N, Zhang M, Ni P. A study of the stability of W/O/W multiple emulsions. J Microencapsul. 1992;9(2):143-51
Yan, N., Zhang, M., & Ni, P. (1992). A study of the stability of W/O/W multiple emulsions. Journal of microencapsulation, 9(2), 143-51.
Yan, N, et al. "A study of the stability of W/O/W multiple emulsions." Journal of microencapsulation vol. 9,2 (1992): 143-51.
Yan N, Zhang M, Ni P. A study of the stability of W/O/W multiple emulsions. J Microencapsul. 1992 Apr-Jun;9(2):143-51. PMID: 1593397.
Copy Download .nbib Format: NLM
The use of liposomes for the preparation of protein-free lipid emulsions models of chylomicron remnants.

Journal of microencapsulation

Vuaridel-Bonanomi ES, Weder HG.
PMID: 1765900
J Microencapsul. 1991 Apr-Jun;8(2):203-14. doi: 10.3109/02652049109071488.

Artificial chylomicron remnants were investigated as a new drug carrier system for the targeting of hepatic parenchymal cells. The emulsions presented here are similar in particle size and composition to natural lipoproteins. The preparations contained triolein, phospholipid, cholesterol and...

Cite
Vuaridel-Bonanomi ES, Weder HG. The use of liposomes for the preparation of protein-free lipid emulsions models of chylomicron remnants. J Microencapsul. 1991;8(2):203-14doi: 10.3109/02652049109071488.
Vuaridel-Bonanomi, E. S., & Weder, H. G. (1991). The use of liposomes for the preparation of protein-free lipid emulsions models of chylomicron remnants. Journal of microencapsulation, 8(2), 203-14. https://doi.org/10.3109/02652049109071488
Vuaridel-Bonanomi, E S, and Weder, H G. "The use of liposomes for the preparation of protein-free lipid emulsions models of chylomicron remnants." Journal of microencapsulation vol. 8,2 (1991): 203-14. doi: https://doi.org/10.3109/02652049109071488
Vuaridel-Bonanomi ES, Weder HG. The use of liposomes for the preparation of protein-free lipid emulsions models of chylomicron remnants. J Microencapsul. 1991 Apr-Jun;8(2):203-14. doi: 10.3109/02652049109071488. PMID: 1765900.
Copy Download .nbib Format: NLM
Use of a gel-forming dipeptide derivative as a carrier for antigen presentation.

Journal of peptide science : an official publication of the European Peptide Society

Vegners R, Shestakova I, Kalvinsh I, Ezzell RM, Janmey PA.
PMID: 9223016
J Pept Sci. 1995 Nov-Dec;1(6):371-8. doi: 10.1002/psc.310010604.

A dipeptide of the formula Fmoc-Leu-Asp and some other related dipeptides were synthesized in solution by standard methods. When such peptides are dissolved in water at concentrations below 1% at 100 degrees C and cooled below 60 degrees C...

Cite
Vegners R, Shestakova I, Kalvinsh I, et al. Use of a gel-forming dipeptide derivative as a carrier for antigen presentation. J Pept Sci. 1995;1(6):371-8doi: 10.1002/psc.310010604.
Vegners, R., Shestakova, I., Kalvinsh, I., Ezzell, R. M., & Janmey, P. A. (1995). Use of a gel-forming dipeptide derivative as a carrier for antigen presentation. Journal of peptide science : an official publication of the European Peptide Society, 1(6), 371-8. https://doi.org/10.1002/psc.310010604
Vegners, R, et al. "Use of a gel-forming dipeptide derivative as a carrier for antigen presentation." Journal of peptide science : an official publication of the European Peptide Society vol. 1,6 (1995): 371-8. doi: https://doi.org/10.1002/psc.310010604
Vegners R, Shestakova I, Kalvinsh I, Ezzell RM, Janmey PA. Use of a gel-forming dipeptide derivative as a carrier for antigen presentation. J Pept Sci. 1995 Nov-Dec;1(6):371-8. doi: 10.1002/psc.310010604. PMID: 9223016.
Copy Download .nbib Format: NLM
A cyclodextrin dimer with a photocleavable linker as a possible carrier for the photosensitizer in photodynamic tumor therapy.

Proceedings of the National Academy of Sciences of the United States of America

Ruebner A, Yang Z, Leung D, Breslow R.
PMID: 10611274
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14692-3. doi: 10.1073/pnas.96.26.14692.

A cyclodextrin dimer has been synthesized with two beta-cyclodextrins linked by a flexible chain containing a carbon-carbon double bond. This dimer binds and solubilizes a phthalocyanine-based photosensitizer that generates singlet oxygen on irradiation. When the complex is irradiated, the...

Cite
Ruebner A, Yang Z, Leung D, et al. A cyclodextrin dimer with a photocleavable linker as a possible carrier for the photosensitizer in photodynamic tumor therapy. Proc Natl Acad Sci U S A. 1999;96(26):14692-3doi: 10.1073/pnas.96.26.14692.
Ruebner, A., Yang, Z., Leung, D., & Breslow, R. (1999). A cyclodextrin dimer with a photocleavable linker as a possible carrier for the photosensitizer in photodynamic tumor therapy. Proceedings of the National Academy of Sciences of the United States of America, 96(26), 14692-3. https://doi.org/10.1073/pnas.96.26.14692
Ruebner, A, et al. "A cyclodextrin dimer with a photocleavable linker as a possible carrier for the photosensitizer in photodynamic tumor therapy." Proceedings of the National Academy of Sciences of the United States of America vol. 96,26 (1999): 14692-3. doi: https://doi.org/10.1073/pnas.96.26.14692
Ruebner A, Yang Z, Leung D, Breslow R. A cyclodextrin dimer with a photocleavable linker as a possible carrier for the photosensitizer in photodynamic tumor therapy. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14692-3. doi: 10.1073/pnas.96.26.14692. PMID: 10611274; PMCID: PMC24709.
Copy Download .nbib Format: NLM
Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides.

Medicinal research reviews

Wagner CR, Iyer VV, McIntee EJ.
PMID: 11058891
Med Res Rev. 2000 Nov;20(6):417-51. doi: 10.1002/1098-1128(200011)20:6<417::aid-med1>3.0.co;2-z.

To overcome the many hurdles preventing the use of antiviral and anticancer nucleosides as therapeutics, the development of a prodrug methodology (i.e., pronucleotide) for the in vivo delivery of nucleotides has been proposed as a solution. The ideal pronucleotide...

Cite
Wagner CR, Iyer VV, McIntee EJ. Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides. Med Res Rev. 2000;20(6):417-51doi: 10.1002/1098-1128(200011)20:6<417::aid-med1>3.0.co;2-z.
Wagner, C. R., Iyer, V. V., & McIntee, E. J. (2000). Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides. Medicinal research reviews, 20(6), 417-51. https://doi.org/10.1002/1098-1128(200011)20:6<417::aid-med1>3.0.co;2-z
Wagner, C R, et al. "Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides." Medicinal research reviews vol. 20,6 (2000): 417-51. doi: https://doi.org/10.1002/1098-1128(200011)20:6<417::aid-med1>3.0.co;2-z
Wagner CR, Iyer VV, McIntee EJ. Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides. Med Res Rev. 2000 Nov;20(6):417-51. doi: 10.1002/1098-1128(200011)20:6<417::aid-med1>3.0.co;2-z. PMID: 11058891.
Copy Download .nbib Format: NLM
Development of a rectal nicotine delivery system for the treatment of ulcerative colitis.

International journal of pharmaceutics

Dash AK, Gong Z, Miller DW, Huai-Yan H, Laforet J.
PMID: 10528093
Int J Pharm. 1999 Nov 10;190(1):21-34. doi: 10.1016/s0378-5173(99)00221-5.

The aims of this investigation were: i. to develop a rectal nicotine delivery system with bioadhesives for the treatment of ulcerative colitis and ii. to evaluate nicotine transport and cytotoxicity of the delivery system using Caco-2 cell culture systems....

Cite
Dash AK, Gong Z, Miller DW, et al. Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. Int J Pharm. 1999;190(1):21-34doi: 10.1016/s0378-5173(99)00221-5.
Dash, A. K., Gong, Z., Miller, D. W., Huai-Yan, H., & Laforet, J. (1999). Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. International journal of pharmaceutics, 190(1), 21-34. https://doi.org/10.1016/s0378-5173(99)00221-5
Dash, A K, et al. "Development of a rectal nicotine delivery system for the treatment of ulcerative colitis." International journal of pharmaceutics vol. 190,1 (1999): 21-34. doi: https://doi.org/10.1016/s0378-5173(99)00221-5
Dash AK, Gong Z, Miller DW, Huai-Yan H, Laforet J. Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. Int J Pharm. 1999 Nov 10;190(1):21-34. doi: 10.1016/s0378-5173(99)00221-5. PMID: 10528093.
Copy Download .nbib Format: NLM
Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte.

Journal of microencapsulation

Freitas C, Müller RH.
PMID: 9972503
J Microencapsul. 1999 Jan-Feb;16(1):59-71. doi: 10.1080/026520499289310.

The contribution of mono-, di- and trivalent ions to the destabilization of solid lipid nanoparticle (SLN) dispersions was investigated, i.e. particle growth and subsequent formation of semi-solid gels. Sodium, calcium and aluminium chloride were added in varying concentrations to...

Cite
Freitas C, Müller RH. Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte. J Microencapsul. 1999;16(1):59-71doi: 10.1080/026520499289310.
Freitas, C., & Müller, R. H. (1999). Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte. Journal of microencapsulation, 16(1), 59-71. https://doi.org/10.1080/026520499289310
Freitas, C, and Müller, R H. "Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte." Journal of microencapsulation vol. 16,1 (1999): 59-71. doi: https://doi.org/10.1080/026520499289310
Freitas C, Müller RH. Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte. J Microencapsul. 1999 Jan-Feb;16(1):59-71. doi: 10.1080/026520499289310. PMID: 9972503.
Copy Download .nbib Format: NLM
Carbohydrate- and related polyol-derived fluorosurfactants: an update.

Carbohydrate research

Riess JG, Greiner J.
PMID: 10968680
Carbohydr Res. 2000 Jul 10;327(1):147-68. doi: 10.1016/s0008-6215(00)00012-4.

A short review of recent literature is presented on the synthesis, biological properties, colloid and surface chemistry, and applications of carbohydrate- and related polyol-derived amphiphiles with perfluoroalkyl hydrophobes.

Cite
Riess JG, Greiner J. Carbohydrate- and related polyol-derived fluorosurfactants: an update. Carbohydr Res. 2000;327(1):147-68doi: 10.1016/s0008-6215(00)00012-4.
Riess, J. G., & Greiner, J. (2000). Carbohydrate- and related polyol-derived fluorosurfactants: an update. Carbohydrate research, 327(1), 147-68. https://doi.org/10.1016/s0008-6215(00)00012-4
Riess, J G, and Greiner, J. "Carbohydrate- and related polyol-derived fluorosurfactants: an update." Carbohydrate research vol. 327,1 (2000): 147-68. doi: https://doi.org/10.1016/s0008-6215(00)00012-4
Riess JG, Greiner J. Carbohydrate- and related polyol-derived fluorosurfactants: an update. Carbohydr Res. 2000 Jul 10;327(1):147-68. doi: 10.1016/s0008-6215(00)00012-4. PMID: 10968680.
Copy Download .nbib Format: NLM
Protein conjugates of defined structure: synthesis and use of a new carrier molecule.

Bioconjugate chemistry

Vilaseca LA, Rose K, Werlen R, Meunier A, Offord RE, Nichols CL, Scott WL.
PMID: 8305521
Bioconjug Chem. 1993 Nov-Dec;4(6):515-20. doi: 10.1021/bc00024a014.

A new carrier molecule, NH2OCH2CO-(Gly)3-[Lys(H-Ser-)]5-Gly-OH, has been synthesized to facilitate the preparation of protein conjugates of defined structure. Special features are as follows: (i) (aminooxy)-acetyl as a terminal group, which reacts specifically to form an oxime bond under very...

Cite
Vilaseca LA, Rose K, Werlen R, et al. Protein conjugates of defined structure: synthesis and use of a new carrier molecule. Bioconjug Chem. 1993;4(6):515-20doi: 10.1021/bc00024a014.
Vilaseca, L. A., Rose, K., Werlen, R., Meunier, A., Offord, R. E., Nichols, C. L., & Scott, W. L. (1993). Protein conjugates of defined structure: synthesis and use of a new carrier molecule. Bioconjugate chemistry, 4(6), 515-20. https://doi.org/10.1021/bc00024a014
Vilaseca, L A, et al. "Protein conjugates of defined structure: synthesis and use of a new carrier molecule." Bioconjugate chemistry vol. 4,6 (1993): 515-20. doi: https://doi.org/10.1021/bc00024a014
Vilaseca LA, Rose K, Werlen R, Meunier A, Offord RE, Nichols CL, Scott WL. Protein conjugates of defined structure: synthesis and use of a new carrier molecule. Bioconjug Chem. 1993 Nov-Dec;4(6):515-20. doi: 10.1021/bc00024a014. PMID: 8305521.
Copy Download .nbib Format: NLM
The physicochemical and biopharmaceutical properties of fragmented keratin as a new drug carrier.

Biological & pharmaceutical bulletin

Noda J, Imai T, Kida K, Otagiri M.
PMID: 8924920
Biol Pharm Bull. 1996 Mar;19(3):466-73. doi: 10.1248/bpb.19.466.

Two types of fragmented keratin were prepared from buffalo horn and hoof using savinase and Na2S, and their physicochemical and biopharmaceutical properties were examined in mice. The number-average molecular weight of enzymatically fragmented keratin (E-FK), chemically fragmented keratin (C-FK),...

Cite
Noda J, Imai T, Kida K, et al. The physicochemical and biopharmaceutical properties of fragmented keratin as a new drug carrier. Biol Pharm Bull. 1996;19(3):466-73doi: 10.1248/bpb.19.466.
Noda, J., Imai, T., Kida, K., & Otagiri, M. (1996). The physicochemical and biopharmaceutical properties of fragmented keratin as a new drug carrier. Biological & pharmaceutical bulletin, 19(3), 466-73. https://doi.org/10.1248/bpb.19.466
Noda, J, et al. "The physicochemical and biopharmaceutical properties of fragmented keratin as a new drug carrier." Biological & pharmaceutical bulletin vol. 19,3 (1996): 466-73. doi: https://doi.org/10.1248/bpb.19.466
Noda J, Imai T, Kida K, Otagiri M. The physicochemical and biopharmaceutical properties of fragmented keratin as a new drug carrier. Biol Pharm Bull. 1996 Mar;19(3):466-73. doi: 10.1248/bpb.19.466. PMID: 8924920.
Copy Download .nbib Format: NLM
Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations.

Bioconjugate chemistry

Ansell SM, Kojic LD, Hankins JS, Sekirov L, Boey A, Lee DK, Bennett AR, Klimuk SK, Harasym TO, Dos Santos N, Semple SC.
PMID: 10411464
Bioconjug Chem. 1999 Jul-Aug;10(4):653-66. doi: 10.1021/bc990005p.

Lipid conjugates of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) (ATTAn) were synthesized as monodisperse analogues of poly(ethylene glycol) (PEG) derivatives used in liposomal drug delivery systems. The new lipids were shown to be at least equivalent to MePEGA-2000-DSPE in assays designed to evaluate...

Cite
Ansell SM, Kojic LD, Hankins JS, et al. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations. Bioconjug Chem. 1999;10(4):653-66doi: 10.1021/bc990005p.
Ansell, S. M., Kojic, L. D., Hankins, J. S., Sekirov, L., Boey, A., Lee, D. K., Bennett, A. R., Klimuk, S. K., Harasym, T. O., Dos Santos, N., & Semple, S. C. (1999). Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations. Bioconjugate chemistry, 10(4), 653-66. https://doi.org/10.1021/bc990005p
Ansell, S M, et al. "Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations." Bioconjugate chemistry vol. 10,4 (1999): 653-66. doi: https://doi.org/10.1021/bc990005p
Ansell SM, Kojic LD, Hankins JS, Sekirov L, Boey A, Lee DK, Bennett AR, Klimuk SK, Harasym TO, Dos Santos N, Semple SC. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations. Bioconjug Chem. 1999 Jul-Aug;10(4):653-66. doi: 10.1021/bc990005p. PMID: 10411464.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26299 entries